17-41149343-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_033188.4(KRTAP4-5):c.425G>A(p.Arg142His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000707 in 1,612,996 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_033188.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KRTAP4-5 | NM_033188.4 | c.425G>A | p.Arg142His | missense_variant | 1/1 | ENST00000343246.6 | NP_149445.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KRTAP4-5 | ENST00000343246.6 | c.425G>A | p.Arg142His | missense_variant | 1/1 | 6 | NM_033188.4 | ENSP00000340546.4 |
Frequencies
GnomAD3 genomes AF: 0.000532 AC: 81AN: 152148Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000511 AC: 126AN: 246640Hom.: 0 AF XY: 0.000531 AC XY: 71AN XY: 133716
GnomAD4 exome AF: 0.000725 AC: 1059AN: 1460732Hom.: 0 Cov.: 30 AF XY: 0.000705 AC XY: 512AN XY: 726558
GnomAD4 genome AF: 0.000532 AC: 81AN: 152264Hom.: 0 Cov.: 32 AF XY: 0.000497 AC XY: 37AN XY: 74440
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 16, 2021 | The c.425G>A (p.R142H) alteration is located in exon 1 (coding exon 1) of the KRTAP4-5 gene. This alteration results from a G to A substitution at nucleotide position 425, causing the arginine (R) at amino acid position 142 to be replaced by a histidine (H). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at